Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
2021 · Nature Communications · 160 citations
https://doi.org/10.1038/s41467-021-23473-6
D
Daniel Junker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.4K
Citations
14
h-index
20
i10-index
Daniel Junker is an academic researcher from Natural and Medical Sciences Institute. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 14, co-authored 29 publications.
ORCID: 0000-0001-6083-1453Papers by this author
worksExploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
2021 · Nature Communications · 91 citations
https://doi.org/10.1038/s41467-021-20973-3
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
2021 · EMBO Reports · 61 citations
https://doi.org/10.15252/embr.202052325
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
2021 · Cell Reports · 59 citations
https://doi.org/10.1016/j.celrep.2021.110169
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
2021 · EMBO Reports · 29 citations
https://doi.org/10.15252/embr.202153865
Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies
2022 · BMC Infectious Diseases · 8 citations
https://doi.org/10.1186/s12879-022-07863-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat